Follow
Roy Haskell
Roy Haskell
Arvinas
Verified email at arvinas.com - Homepage
Title
Cited by
Cited by
Year
Drug–polymer–water interaction and its implication for the dissolution performance of amorphous solid dispersions
Y Chen, C Liu, Z Chen, C Su, M Hageman, M Hussain, R Haskell, ...
Molecular pharmaceutics 12 (2), 576-589, 2015
1612015
Initial drug dissolution from amorphous solid dispersions controlled by polymer dissolution and drug-polymer interaction
Y Chen, S Wang, S Wang, C Liu, C Su, M Hageman, M Hussain, ...
Pharmaceutical research 33, 2445-2458, 2016
1182016
Sodium lauryl sulfate competitively interacts with HPMC-AS and consequently reduces oral bioavailability of posaconazole/HPMC-AS amorphous solid dispersion
Y Chen, S Wang, S Wang, C Liu, C Su, M Hageman, M Hussain, ...
Molecular pharmaceutics 13 (8), 2787-2795, 2016
672016
Moisture-induced amorphous phase separation of amorphous solid dispersions: molecular mechanism, microstructure, and its impact on dissolution performance
H Chen, Y Pui, C Liu, Z Chen, CC Su, M Hageman, M Hussain, R Haskell, ...
Journal of pharmaceutical sciences 107 (1), 317-326, 2018
662018
Targeted delivery of a poorly water-soluble compound to hair follicles using polymeric nanoparticle suspensions
M Morgen, GW Lu, D Du, R Stehle, F Lembke, J Cervantes, S Ciotti, ...
International journal of pharmaceutics 416 (1), 314-322, 2011
582011
Characterization of submicron systems via optical methods
RJ Haskell
Journal of pharmaceutical sciences 87 (2), 125-129, 1998
551998
Investigations of protein structure with optical spectroscopy: bovine growth hormone
HA Havel, RS Chao, RJ Haskell, TJ Thamann
Analytical chemistry 61 (7), 642-650, 1989
541989
Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery
M Morgen, A Saxena, XQ Chen, W Miller, R Nkansah, A Goodwin, J Cape, ...
European Journal of Pharmaceutics and Biopharmaceutics 117, 212-223, 2017
522017
Discovery of BMS-955176, a second generation HIV-1 maturation inhibitor with broad spectrum antiviral activity
A Regueiro-Ren, Z Liu, Y Chen, N Sin, SY Sit, JJ Swidorski, J Chen, ...
ACS Medicinal Chemistry Letters 7 (6), 568-572, 2016
522016
Auditory duration discrimination in the parakeet (Melopsittacus undulatus).
RJ Dooling, RJ Haskell
The Journal of the Acoustical Society of America 63 (5), 1640-1642, 1978
471978
Centrally delivered BACE1 inhibitor activates microglia, and reverses amyloid pathology and cognitive deficit in aged Tg2576 mice
DR Thakker, S Sankaranarayanan, MR Weatherspoon, J Harrison, ...
Journal of Neuroscience 35 (17), 6931-6936, 2015
462015
Site-directed mutagenesis to probe protein folding: evidence that the formation and aggregation of a bovine growth hormone folding intermediate are dissociable processes
SR Lehrman, JL Tuls, HA Havel, RJ Haskell, SD Putnam, CSC Tomich
Biochemistry 30 (23), 5777-5784, 1991
461991
Application of a Mixture Experimental Design in the Optimization of a Self‐Emulsifying Formulation with a High Drug Load
P Gao, MJ Witt, RJ Haskell, KM Zamora, JR Shifflett
Pharmaceutical development and technology 9 (3), 301-309, 2005
442005
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
J Cantley, X Ye, E Rousseau, T Januario, BD Hamman, CM Rose, ...
Nature Communications 13 (1), 6814, 2022
382022
Physical characterization of nanoparticles
RJ Haskell
Nanoparticle Technology for Drug Delivery, 127-162, 2006
342006
Discovery of a hepatitis C virus NS5B replicase palm site allosteric inhibitor (BMS-929075) advanced to phase 1 clinical studies
KS Yeung, BR Beno, K Parcella, JA Bender, KA Grant-Young, A Nickel, ...
Journal of Medicinal Chemistry 60 (10), 4369-4385, 2017
302017
Laboratory scale milling process
RJ Haskell
US Patent 6,814,319, 2004
282004
A Combination Turbidity and Supernatant Microplate Assay to Rank‐Order the Supersaturation Limits of Early Drug Candidates
JS Morrison, MJ Nophsker, RJ Haskell
Journal of pharmaceutical sciences 103 (10), 3022-3032, 2014
272014
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a …
A Regueiro-Ren, JJ Swidorski, Z Liu, Y Chen, N Sin, SY Sit, J Chen, ...
Journal of Medicinal Chemistry 61 (16), 7289-7313, 2018
242018
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
TT Kararli, MJ Kontny, S Desai, MJ Hageman, RJ Haskell
US Patent 7,172,769, 2007
24*2007
The system can't perform the operation now. Try again later.
Articles 1–20